Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Covarrubias-Pinto A, Acua AI, Beltrn FA, et al
doi: 10.1016/j.ygeno.2021.01.022 70 ShuK.LiuX
A study experimented VC in combination with each of eribulin mesylate, tamoxifen, fulvestrant, and trastuzumab on a variety of breast cancer cell lines (MCF7, SK-BR3, MDA-MB-231, and breast epithelial cells MCF10A), have shown that high-dose VC with each of those anti-cancer drugs had decreased the cell viability of cancer cells more comprehensively than high-dose of VC or chemotherapy alone (90)
1:15,000) from LI-COR Biosciences (Lincoln, Nebraska, USA), and scanned using an Odyssey Infrared imaging system (Model 9120, LI-COR Biosciences)
von effective nature), dafr sogar weniger Glycin als das Reisprotein
